Companies & Industry »Company News
Glaxosmithkline Pharma Ltd - Company News

BSE   23 Apr 14 | 12:00 AM

2463.15 -23.65 (-0.95%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 500660
Face Value: 10

NSE   23 Apr 14 | 12:00 AM

2457.10 -25.25 (-1.02%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 2,497.40 (-1.37%)
1 Month : Rs 2,551.65 (-3.47%)
1 Year : Rs 2,195.70 (12.18%)
change companytradenow

  • 24 Apr 14
    12:50 AM
    The multi-billion dollar three-way deal of Novartis with GlaxoSmithKline (GSK) and Eli Lilly is likely to trigger merger control approvals from various anti-trust authorities, including a scrutiny by Competition Commission of India (CCI), industry
  • 23 Apr 14
    12:58 AM
    Swiss drug major Novartis’ multi-billion-dollar overhaul through deals with two multinational firms — GlaxoSmithKline (GSK) and Eli Lilly — is likely to have an impact on the Indian market, too, as all the three companies have
    12:47 AM
    GlaxoSmithKline's $1-billion open offer to raise stake in its Indian arm, GlaxoSmithKline Pharmaceuticals, had received a shot in the arm from foreign institutional investors (FII), shareholding data for the March quarter showed.
  • 18 Apr 14
    12:02 AM
    GlaxoSmithKline Pharmaceuticals today posted 42.87% decline in its net profit at Rs 96.54 crore for the first quarter ended March 31, 2014, as the company continued to be impacted by the revamped price control order.
  • 29 Mar 14
    12:49 AM
    After Crocin Advance, it’s the turn of GlaxoSmithKline (GSK) Pharmaceutical’s top-selling paracetamol brand Calpol syrup to come under the regulator’s scanner for allegedly overcharging consumers.
  • 10 Mar 14
    03:50 PM
    GlaxoSmithKline plc has increased its stake in its publicly-listed pharmaceuticals subsidiary in India (GlaxoSmithKline Pharmaceuticals Limited) from 50.7% to 75%, following by the recent open offer.
    02:04 PM
    The over $1 billion share re-purchase by UK's Glaxo Group in its Indian arm GlaxoSmithKline Pharmaceuticals has received full subscription helping the promoters increase their shareholding to 75%.
    12:07 PM
    GlaxoSmithKline Pharmaceuticals is trading lower by 3% at Rs 2,570, extending its past four day’s fall, after the parent company GlaxoSmithKline plc said that it has successfully increased its stake in pharmaceuticals subsidiary in India and it will
  • 04 Mar 14
    05:38 PM
    The Glaxo SmithKline Pharma (GSK Pharma) stock, which has been on the rise since mid-December (when its foreign parent announced plans to raise its stake in the company), hit an all-time high of Rs 3,054.4 on Monday.
  • 03 Mar 14
    05:11 PM
    The share price of GlaxoSmithKline Pharma (GSK Pharma) hit 52-week high at Rs 3054.4 apiece on Mondaydue to investors' pick on expectations for a further upsurge towards the openoffer price of Rs 3100 apiece.
  • 19 Feb 14
    12:48 AM
    GlaxoSmithKline (GSK) Pharma’s earnings for the quarter ended December fell short of expectations, as the company grappled with pricing policy, trade-related disturbances and supply constraints.
  • 16 Jan 14
    09:30 AM
    After dipping 3.3% and 6.3% y-o-y in September and October in the back of New Pharma Pricing Policy (NPPP) implementation, the overall volume growth in the pharmaceutical space has started to rebound.
  • 18 Dec 13
    12:14 AM
    GlaxoSmithKline will stop paying doctors to promote its products at events and remove individual sales targets for its marketing staff in a first for the drugs industry looking to recover from scandals over improper sales practices.
  • 17 Dec 13
    12:59 AM
    British pharmaceutical, biologics, vaccine and consumer healthcare group, GlaxoSmithKline Plc, has initiated an open offer to increase stake in its publicly listed subsidiary in India, GlaxoSmithKline Pharmaceuticals Ltd.
  • 16 Dec 13
    10:38 AM
    Glaxosmithkline Pharma plc has initiated an open offer to buy 20,609,774 shares, representing 24.33% of the total voting share capital, from the public shareholders of its India-listed arm – GSK Pharma – for Rs 3,100 per share.
  • 08 Oct 13
    04:41 AM
    British drugmaker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children.


Company Price Gain (%)
Larsen & Toubro1,377.302.48
GAIL (India)384.201.48
B H E L189.301.42
Tata Steel426.601.32
M & M1,036.751.22

Online Portfolio

You can create Online Portfolio here using the below button.